Finance committee flags steep prescription cost spike that adds $1.02M to next year’s budget

At the March 17 finance committee meeting, district finance staff told trustees that renewal rates for benefits would materially increase next year and that those increases have immediate budget consequences.

Ms. Mosley said the district’s medical insurance renewal came in at +2.85% versus a prior projected decline, adding roughly $193,000 to the 2026–27 budget. More consequentially, prescription costs arrived at a 39.2% increase that Ms. Mosley calculated would add about $1,017,896 to next year’s budget. Administration reported WSSD had the fifth‑highest prescription increase in the state and that 66% of the rise for WSSD was driven by specialty medications, with GLP‑1 weight‑loss therapies accounting for a significant share.

Ms. Mosley explained the trust’s blended calculation method (a 24‑month blend weighted toward recent months) and cautioned that the formula means elevated prescription costs could persist into the following budget year. Board members asked whether plan design changes are contractually constrained and whether GLP‑1 therapies could be excluded or managed; administration said the district controls the offered plan design but that member contribution percentages and some contractual terms are fixed unless renegotiated.

Finance staff also provided updates on procurement and contracts. Four contracts were slated for board approval: the district audit engagement (new firm by merger, slightly reduced cost), solicitor services (transition to a new firm with the same lawyers and rates), Serfass Associates for engineering, and Emergis Healthcare Staffing, which was presented as a lower‑cost vendor option for certain specialized staff (18–25% lower than some current vendors).

Next steps: administrators said they will finalize large RFP awards (custodial, HVAC) and provide a refined proposed budget in April. Trustees requested clearer visibility into how savings from procurement and supply reductions will be quantified and how benefit plan design options could mitigate multi‑year risk.